1Garcia J, Jones GS, Acosta AA, et al. Human menopausal Gonadotropin/human ehorionie gonadotropin follicular maturation for oocyte aspiration. phase Ⅱ1981. Fertil Steril, 1983, 39(1):174-179.
2Land J, Yarmolinskaya M, Dumoulin J et al. High - dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril, 1996, 65:961-965.
3Frandstrom M, Akerlof E, Sjoblom P et al. Serum levels of luteinizing and follicle - stimulating hormones in normal and poor responding patients undergoing ovarian stimulation with urofollitropin after pituitary down regulation. Gynecol Endocrinol, 1997, 11 : 25-28.
4Raga F, Bonilla- Musoles F, Casan EM et al. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Repred, 1999, 14:1431-1434.
5Rombauts L, Suikkari A, MacLachlan V et al. Recruitment of follicles by recombinant human follicle - stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril, 1998, 69 : 665-669.
6Faber BM , MayerJ , CoxB et al. Cessation of gonadotropin - releasing hormone agonist therapy combined with high - dose gonadotropin stimulation yields favorable pregnancy results in low responders, Fertil Steril,1998, 69 (5) : 826-830.
7Brzyski B, Muasher S, Droesch K et al, Follicular atresia associated with concurrent initiation of gonadotropin releasing hormone agonist and follicle stimulating hormone for oocytes recruitment. Fertil Steril, 1988,50:917-921.
8Surrey E, Bower J, Hill D et al, Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril, 1998, 69:419-424.
9Keay SD , Liversedge NH , Mathur RS et al, Assisted conception following poor ovarian response to gonadotrophin stimulation, Br. J, Obstet Gynaecol , 1997, 104:521-527.
10Faddy M J, Gosden RG, A model confoming the decline in follicle numbers to the age of menopause in women. Hum Reprod, 1996, 11(7) : 1484-1486.
二级参考文献24
1[1]Albano C, Smitz J, Camus M, et al. Comparison of different of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril,1997,67:917-922.
2[2]Albano C, Grimbizis G, Smitz J, et al. The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. Fertil Steril,1998,70:357-359.
3[3]Felverbaum R, Diedrich K. Ovarian stimulation in ART: use of GnRH-antagonists. Fertil Reprod Med. Proceedings of the XVI World Congress on Fertility and Sterility, San Francisco,1998.113-124.
4[4]Olivennes F, Alvarez S, Bouchard P, et al. The use of GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod,1998,13:2411-2414.
5[5]Michael CP, Crowley WF. Gonadotropin-releasing hormone and its analoges. Annu Rev Med,1994,45:391-405.
6[6]Rivier JE, Poter J, Rivier CL, et al. new effective gonadotropin releasing hormone antagonist with minimal potency for histamine release in vitro. J Med Chem,1986,29:1846-1851.
7[7]Marshall LA, Fluker MR, Jaffe RB, et al. Inhibition of follicular development by a potent antagonist analog of gonadotropin-releasing hormone(Detirelix). J Clin Endocrinol Metab,1991,72:933-937.
8[8]Frydman R, Taieb J, Cornel C, et al. Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation, Fertil Steril,1991,56:923-928.
9[9]Olivennnes F, Taieb J, Fanchin R, et al. The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. Fertil Steril,1994,62:468-476.
10[10]Fluker MR, Marshall LA, Monroe SE, et al. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phase of the menstrual cycle. J Clin Endocrinol Metab,1991,72:912-919.
9Keay SD, Liversedge NH, Mathur RS, et al. Assisted conception following poor ovarian response to gonadotrophin stimulation[J]. British J Obstet Gynecol. 1997, 104(5) 521-527.
10Ulug U, Ben Shlomo I, Turan E, et al. Conception rates following assisted reproduction in poor responder patients~ a retrospective study in 300 consecutive cycles[J]. Repro Biomed Online,2003,6(4) :439-443.
